GraphDiffMed: Knowledge-Constrained Differential Attention with Pharmacological Graph Priors for Medication Recommendation
arXiv:2605.20188v1 Announce Type: new Abstract: Recommending safe and effective medication combinations from electronic health records (EHRs) is a core clinical AI problem, yet it remains difficult because patient trajectories are long, noisy, and clinically heterogeneous. Existing methods typically excel at either temporal modeling across visits or pharmacological knowledge integration (e.g., drug-drug interactions, DDIs), but rarely achieve both while robustly suppressing noise. We present GraphDiffMed, a knowledge-constrained medication recommendation framework built on dual-scale Different
The increasing availability of electronic health records (EHRs) and advancements in AI, particularly graph neural networks, enable more sophisticated approaches to medical recommendation systems.
Improving medication recommendation systems leads to safer, more effective patient care, reduces adverse drug events, and optimizes healthcare resource allocation.
Medication recommendation systems are moving beyond simple data correlations, integrating complex pharmacological knowledge and temporal patient data for more robust and personalized treatment guidance.
- · AI healthcare platforms
- · Pharmaceutical research and development
- · Hospitals and healthcare providers
- · Patients
- · Legacy clinical decision support systems
More precise and personalized medication regimens will become standard, reducing trial-and-error in treatment.
The integration of AI with EHRs could accelerate drug discovery by identifying novel drug combinations and interactions.
Ethical and regulatory frameworks for AI-driven clinical decisions will need to evolve rapidly to ensure patient safety and accountability.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG